Gibson Leaves Affy, Collins Gets a Prize, Haas Takes the Helm at Plexigen, and More | GenomeWeb
NEW YORK (GenomeWeb News) - James Gibson has resigned his position as Affymetrix’s VP and principal accounting officer. Gibson is leaving his post at Affy in order to pursue a senior financial management job at another company, Affy said in a filing with the US Securities and Exchange Commission.
 

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.